Emerging Company Profile: Chinese siRNA Specialist Sirius All In On Cardiovascular Disease

Potential Once-Yearly Regimen

 
• By Dexter Jie Yan
  
cardiovascular diseases
Chinese siRNA therapy developer aims at cardiovascular diseases with potential once-yearly regimen • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia